Red meat consumption and cancer: Reasons to suspect involvement of bovine infectious factors in colorectal cancer
International Journal of Cancer,

zur Hausen H et al. – The available data are compatible with the interpretation that a specific beef factor, suspected to be one or more thermo–resistant potentially oncogenic bovine viruses (e.g. polyoma–, papilloma–, or possibly single–stranded DNA viruses) may contaminate beef preparations and lead to latent infections in the colorectal tract. Preceding, concomitant or subsequent exposure to chemical carcinogens arising during cooking procedures should result in increased risk for colorectal cancer synergistic with these infections.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Anti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories Cancer Chemotherapy and Pharmacology, June 17, 2014    Review Article

2 Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer? Full Text World Journal of Gastroenterology, June 3, 2014    Free full text    Review Article

3 Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy European Journal of Nuclear Medicine & Molecular Imaging, June 13, 2014    Clinical Article

4 KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX Annals of Surgical Oncology, June 12, 2014    Clinical Article

5 Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: A randomized clinical trial JAMA, May 15, 2014    Evidence Based Medicine    Clinical Article

6 Management of colorectal cancer presenting with synchronous liver metastases Nature Reviews Clinical Oncology, June 24, 2014    Clinical Article

7 Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma Tumor Biology, June 12, 2014    Clinical Article

8 Prognostic and predictive significance of MSI in stages II/III colon cancer Full Text World Journal of Gastroenterology, June 16, 2014    Free full text    Clinical Article

9 Characterisation of familial colorectal cancer type X, Lynch syndrome, and non-familial colorectal cancer British Journal of Cancer, June 13, 2014    Clinical Article

10 Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: Surgical end points from National Surgical Adjuvant Breast and Bowel Project Trial R-04 Journal of Clinical Oncology, May 22, 2014    Clinical Article

11 Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial The Lancet Oncology, May 27, 2014    Clinical Article

12 The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer Cancer Treatment Reviews, June 23, 2014    Review Article

13 Laparoscopic vs open extended right hemicolectomy for colon cancer World Journal of Gastroenterology, June 24, 2014    Clinical Article

14 Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer Clinical Cancer Research, June 12, 2014    Clinical Article

15 C-reactive protein and colorectal cancer mortality in US adults Cancer Epidemiology, Biomarkers & Prevention, June 5, 2014    Clinical Article

16 Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases Full Text Journal of Clinical Oncology, April 15, 2013    Free full text    Clinical Article

17 Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer Cancer, June 16, 2014    Clinical Article

18 A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine? British Journal of Cancer, April 21, 2014    Clinical Article

19 Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study The Lancet Oncology, May 27, 2014    Clinical Article

20 Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization American Journal of Clinical Oncology, June 3, 2014    Review Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close